Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
International Journal of Obesity
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
December 2001, Volume 25, Supplement 4, Pages S8-S11
Table of contents    Previous  Abstract  Next   Article  PDF
Paper
How does sibutramine work?
M E J Lean

Department of Human Nutrition, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK

Correspondence to: M E J Lean, Department of Human Nutrition, University of Glasgow, Queen Elizabeth Building, Glasgow, G31 2ER, UK. E-mail: lean@clinmed.gla.ac.uk

Abstract

Sibutramine offers three types of benefit in weight management: by enhancing weight loss, by improving weight maintenance and by reducing the comorbidities of obesity. The clinical effects of sibutramine are explained through its known mode of action as a serotonin (5-HT) and noradrenaline reuptake inhibitor (SNRI). This dual mechanism of action results in two synergistic physiological effects¾a reduction in energy intake and an increase in energy expenditure, which combine to promote and maintain weight loss.

International Journal of Obesity (2001) 25, Suppl 4, S8-S11.

Keywords

sibutramine; serotonin and noradrenaline reuptake inhibitor (SNRI); energy intake; energy expenditure; weight loss

December 2001, Volume 25, Supplement 4, Pages S8-S11
Table of contents    Previous  Abstract  Next   Article  PDF
Privacy Policy © 2001 Nature Publishing Group